東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Biologics to treat substance use dis...

Montoya, Ivan D.

Linked to FindBook

Google Book

Amazon

博客來

Biologics to treat substance use disorders = vaccines, monoclonal antibodies, and enzymes /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Biologics to treat substance use disorders/ edited by Ivan D. Montoya.
Reminder of title:	vaccines, monoclonal antibodies, and enzymes /
other author:	Montoya, Ivan D.
Published:	Cham :Springer International Publishing : : 2016.,
Description:	xvi, 453 p. :ill., digital ;24 cm.
[NT 15003449]:	Introduction -- PART I: Vaccines: Introduction -- Nicotine -- Cocaine -- Heroin -- Metamphetamine -- PART II: Monoclonal antibodies: Introduction -- Cocaine -- Metamphetamine -- PCP -- PART III: Enzymes: Introduction -- Butyrylcholinesterase -- Cocaine Esterase -- PART IV: New strategies to optimize the development of biologics: Adenovirus based vaccines -- Nanotechnology based vaccines -- Protein Nanoparticles -- DNA Scaffolded Vaccines -- Single Hapten Conjugate Therapeutic Vaccine -- Vaccine Adjuvants -- Laser Adjuvant -- Peptide Conjugates & Cytokine Adjuvants -- T. brucei: A Platform for Immunization -- Vaccines for SUDs and HIV infection -- New Monoclonal Antibodies -- Protein Engineered for Controlled Duration of Action -- PART V: Ethical aspects of biologics to treat SUDs.
Contained By:	Springer eBooks
Subject:	Substance abuse - Chemotherapy. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-23150-1
ISBN:	9783319231501$q(electronic bk.)

Biologics to treat substance use disorders = vaccines, monoclonal antibodies, and enzymes /
Biologics to treat substance use disordersvaccines, monoclonal antibodies, and enzymes /[electronic resource] :edited by Ivan D. Montoya. - Cham :Springer International Publishing :2016. - xvi, 453 p. :ill., digital ;24 cm.

Introduction -- PART I: Vaccines: Introduction -- Nicotine -- Cocaine -- Heroin -- Metamphetamine -- PART II: Monoclonal antibodies: Introduction -- Cocaine -- Metamphetamine -- PCP -- PART III: Enzymes: Introduction -- Butyrylcholinesterase -- Cocaine Esterase -- PART IV: New strategies to optimize the development of biologics: Adenovirus based vaccines -- Nanotechnology based vaccines -- Protein Nanoparticles -- DNA Scaffolded Vaccines -- Single Hapten Conjugate Therapeutic Vaccine -- Vaccine Adjuvants -- Laser Adjuvant -- Peptide Conjugates & Cytokine Adjuvants -- T. brucei: A Platform for Immunization -- Vaccines for SUDs and HIV infection -- New Monoclonal Antibodies -- Protein Engineered for Controlled Duration of Action -- PART V: Ethical aspects of biologics to treat SUDs.

This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs) The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. In addition, the text covers a wide range of new strategies designed to optimize the development and efficacy of biologics. Unlike any other resource, this book reviews how biologics offer exciting new therapeutic opportunities for various psychiatric conditions. Written by experts in the field, Biologics to Treat Substance Use Disorders is as an authoritative reference for psychiatrists, psychologists, and all other medical professionals working with patients suffering from Substance Use Disorders.

ISBN: 9783319231501$q(electronic bk.)

Standard No.: 10.1007/978-3-319-23150-1doiSubjects--Topical Terms:

597369
Substance abuse
--Chemotherapy.

LC Class. No.: RC564

Dewey Class. No.: 616.86061

Biologics to treat substance use disorders = vaccines, monoclonal antibodies, and enzymes /
LDR:02777nmm a2200313 a 4500 001 2030022
003 DE-He213
005 20160810085218.0
006 m d
007 cr nn 008maaau
008 160908s2016 gw s 0 eng d
020 $a 9783319231501$q(electronic bk.)
020 $a 9783319231495$q(paper)
024 7 $a 10.1007/978-3-319-23150-1 $2 doi
035 $a 978-3-319-23150-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC564
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
082 0 4 $a 616.86061 $2 23
090 $a RC564 $b .B615 2016
245 0 0 $a Biologics to treat substance use disorders $h [electronic resource] : $b vaccines, monoclonal antibodies, and enzymes / $c edited by Ivan D. Montoya.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xvi, 453 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- PART I: Vaccines: Introduction -- Nicotine -- Cocaine -- Heroin -- Metamphetamine -- PART II: Monoclonal antibodies: Introduction -- Cocaine -- Metamphetamine -- PCP -- PART III: Enzymes: Introduction -- Butyrylcholinesterase -- Cocaine Esterase -- PART IV: New strategies to optimize the development of biologics: Adenovirus based vaccines -- Nanotechnology based vaccines -- Protein Nanoparticles -- DNA Scaffolded Vaccines -- Single Hapten Conjugate Therapeutic Vaccine -- Vaccine Adjuvants -- Laser Adjuvant -- Peptide Conjugates & Cytokine Adjuvants -- T. brucei: A Platform for Immunization -- Vaccines for SUDs and HIV infection -- New Monoclonal Antibodies -- Protein Engineered for Controlled Duration of Action -- PART V: Ethical aspects of biologics to treat SUDs.
520 $a This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs) The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. In addition, the text covers a wide range of new strategies designed to optimize the development and efficacy of biologics. Unlike any other resource, this book reviews how biologics offer exciting new therapeutic opportunities for various psychiatric conditions. Written by experts in the field, Biologics to Treat Substance Use Disorders is as an authoritative reference for psychiatrists, psychologists, and all other medical professionals working with patients suffering from Substance Use Disorders.
650 0 $a Substance abuse $x Chemotherapy. $3 597369
650 0 $a Biologicals. $3 2045998
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Psychopharmacology. $3 568143
650 2 4 $a Pharmacotherapy. $3 1978501
650 2 4 $a Pharmacology/Toxicology. $3 890953
700 1 $a Montoya, Ivan D. $3 2181392
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-23150-1
950 $a Medicine (Springer-11650)